Literature DB >> 33767239

Epidemiology and prognosis in young lung cancer patients aged under 45 years old in northern China.

Jin Shi1, Daojuan Li1, Di Liang1, Yutong He2.   

Abstract

To explore the epidemiological characteristics and prognosis of lung cancer in patients aged under 45 years old in northern China. The population-based database about lung cancer cases aged under 45y selected form the Hebei Provincial Cancer Registry Center from 2010-2015. Mortality data of young death from 1973 to 1975, 1990 to 1992, and 2004 to 2005 were extracted from the national retrospective survey of death. Mortality rates were calculated by the mortality database above in this analysis. Consecutive, 954 non-selected younger patients (< 45 years) and 2261 selected older patients (≥ 45 years) with pathologically diagnosed lung cancer treated at the Fourth Hospital of Hebei Medical University were included as the hospital-based database. Epidemiological, treatment outcomes and prognosis status from 2010 to 2017 were documented. A comparison with younger and older patients was also made. Multivariate analysis with young lung cancer patients was calculated by Cox regression model. The younger lung cancer mortality rate tended to slightly increase in Hebei Province, from 1.04 per100 000 in 1973 to 2.01 per 100 000 in 2015, but the PDR tended to decrease over the last 40 years. There were 954 younger and 2261 older lung cancer patients included in the hospital-based database. The proportions of patients who were female (50.84% vs 34.85%), family history of cancer (12.37% vs 6.32%), advanced stage at diagnosis (65.46% vs 60.77%) and adenocarcinoma (65.27% vs 61.11%) were relatively higher in the younger group than in the older group. The median OS were 23.0 months and 27.0 months between younger and older, the OS difference existed between the two groups (P = 0.001). In the younger patients, Cox regression showed that a family history of cancer, symptoms at diagnosis, pathology, stage at diagnosis and surgery were confirmed as independent factors affecting the prognosis. Mortality rates among younger lung cancer patients showed an increasing trend in northern China. The younger account for small but have unique characteristics, with higher proportions of female, family history of cancer, adenocarcinoma and advanced stages than the older group and had a trend of worse OS.

Entities:  

Year:  2021        PMID: 33767239     DOI: 10.1038/s41598-021-86203-4

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  52 in total

1.  Analysis of the molecular and clinicopathologic features of surgically resected lung adenocarcinoma in patients under 40 years old.

Authors:  Ting Ye; Yunjian Pan; Rui Wang; Haichuan Hu; Yang Zhang; Hang Li; Lei Wang; Yihua Sun; Haiquan Chen
Journal:  J Thorac Dis       Date:  2014-10       Impact factor: 2.895

2.  Changing cancer survival in China during 2003-15: a pooled analysis of 17 population-based cancer registries.

Authors:  Hongmei Zeng; Wanqing Chen; Rongshou Zheng; Siwei Zhang; John S Ji; Xiaonong Zou; Changfa Xia; Kexin Sun; Zhixun Yang; He Li; Ning Wang; Renqiang Han; Shuzheng Liu; Huizhang Li; Huijuan Mu; Yutong He; Yanjun Xu; Zhentao Fu; Yan Zhou; Jie Jiang; Yanlei Yang; Jianguo Chen; Kuangrong Wei; Dongmei Fan; Jian Wang; Fangxian Fu; Deli Zhao; Guohui Song; Jianshun Chen; Chunxiao Jiang; Xin Zhou; Xiaoping Gu; Feng Jin; Qilong Li; Yanhua Li; Tonghao Wu; Chunhua Yan; Jianmei Dong; Zhaolai Hua; Peter Baade; Freddie Bray; Ahmedin Jemal; Xue Qin Yu; Jie He
Journal:  Lancet Glob Health       Date:  2018-05       Impact factor: 26.763

3.  MILD trial, strong confirmation of lung cancer screening efficacy.

Authors:  Matthew B Schabath; Denise R Aberle
Journal:  Nat Rev Clin Oncol       Date:  2019-09       Impact factor: 66.675

4.  [Lung cancer incidence and mortality in China in 2013].

Authors:  W Q Chen; T T Zuo; R S Zheng; H M Zeng; S W Zhang; J He
Journal:  Zhonghua Zhong Liu Za Zhi       Date:  2017-10-23

Review 5.  Cancer screening in the United States, 2016: A review of current American Cancer Society guidelines and current issues in cancer screening.

Authors:  Robert A Smith; Kimberly Andrews; Durado Brooks; Carol E DeSantis; Stacey A Fedewa; Joannie Lortet-Tieulent; Deana Manassaram-Baptiste; Otis W Brawley; Richard C Wender
Journal:  CA Cancer J Clin       Date:  2016-01-21       Impact factor: 508.702

6.  Cancer statistics in China, 2015.

Authors:  Wanqing Chen; Rongshou Zheng; Peter D Baade; Siwei Zhang; Hongmei Zeng; Freddie Bray; Ahmedin Jemal; Xue Qin Yu; Jie He
Journal:  CA Cancer J Clin       Date:  2016-01-25       Impact factor: 508.702

7.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

8.  Cancer incidence and mortality in Hebei province, 2013.

Authors:  Yutong He; Di Liang; Daojuan Li; Jin Shi; Jing Jin; Jingbo Zhai; Denggui Wen; Baoen Shan
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

Review 9.  Epidemiology of lung cancer in China.

Authors:  Maomao Cao; Wanqing Chen
Journal:  Thorac Cancer       Date:  2018-11-28       Impact factor: 3.500

10.  Incidence and mortality of lung cancer in China, 2008-2012.

Authors:  Shuzheng Liu; Qiong Chen; Lanwei Guo; Xiaoqin Cao; Xibin Sun; Wanqing Chen; Jie He
Journal:  Chin J Cancer Res       Date:  2018-12       Impact factor: 5.087

View more
  4 in total

1.  The association between different hormone replacement therapy use and the incidence of lung cancer: a systematic review and meta-analysis.

Authors:  Hui Wen; Xuefeng Lin; Daqiang Sun
Journal:  J Thorac Dis       Date:  2022-02       Impact factor: 2.895

Review 2.  EML4-ALK fusion gene in non-small cell lung cancer.

Authors:  Yu Lei; Yan Lei; Xiang Shi; Jingjing Wang
Journal:  Oncol Lett       Date:  2022-06-24       Impact factor: 3.111

3.  Clinical features and surgical outcomes of young patients with lung adenocarcinoma manifesting as ground glass opacity.

Authors:  Rirong Qu; Dehao Tu; Yixin Cai; Wei Ping; Xiangning Fu
Journal:  Front Oncol       Date:  2022-09-14       Impact factor: 5.738

4.  Diagnostic value of conventional tumor markers in young patients with pulmonary nodules.

Authors:  Lihuan Xu; Zhiming Su; Baosong Xie
Journal:  J Clin Lab Anal       Date:  2021-07-23       Impact factor: 2.352

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.